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Computational studies have shown that cage skeletons (7) have the tendency to impose
a 310-helix as well as an αL-helix on the polypepeptide chain.  Residues such as 7 are the
useful tools for study of the conformational preferences of peptide models, the design of
peptide analogues with improved pharmacokinetics profiles and the development of
pharmacophore models.  Synthesis of pentacycloundecane amino acid analogue suitable
for peptide synthesis would enable us to verify the computational predictions and to
contribute to this very active field of research.
The sterically hindered 8-amino-pentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-carboxylic














































Progress to incorporate 7 into a non-natural peptides is reported.  A computational
investigation on the regioselective acetylation of hydantoin derivatives which includes
PCU hydantoin, 5.5-dimethylhydantoin and 5-methylhydantoin is also reported.  The
results of the computational investigation initiated the regioselective synthesis of the
mono-Boc and bis-Boc derivatives of 5,5-dimethylhydantoin and 5-methylhydantoin.
These compounds have not been reported before.
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Polycarbocyclic “cage” compounds have captured the attention, interest and
imagination of many synthetic organic chemists over the past few years.1,2,3,4,5,6 The
attention was encouraged by the discovery of the anti-viral activities of amantadine (1)
and memantine (2) against the influenza viruses.6 The research interest was also
stimulated by the discovery of the anti-Parkinson activity7 of 1 and rimantadine (3).
The two amino derivatives (1 and 3) show antagonist behaviour towards the clinically





1  R1=H, R2=H 
2  R1=CH3, R2=CH3
3
A number of amino-adamantane derivatives exist which have shown pharmacological
effects including antiviral, antibacterial, antifungal and anti-protozoal activity.6
Discovery of the anti-viral activity of adamantane derivatives initiated further studies
into related polycyclic cage compounds.6,8 Some 4-amino-(D3)-trishomocubane
derivatives have shown promising in-vivo activity against the Herp simplex II and
influenza A2 viruses.8 Pentacycloundecylamines such as 6 exhibit promising
anticataleptic activity in comparison to that of adamantine (1).  Further studies indicated
that the series of D3-trishomocubanes (4 and 5) show potential as anti-Parkinsonian
agents.8
4  R1=H, R2=C6H5




A number of pentacycloundecane derivatives were found to possess analgesic and anti-
inflammatory properties,9 calcium channel antagonism and neuroprotective activity.6
Literature has revealed that the incorporation of cage structures into drugs induces a
range of positive effects on the pharmaceutical action of the drugs.10
Successful therapeutic drugs must induce an optimal concentration of the drug at the
site of action and should also maintain that for an adequate period of time.11  The field
of designing suitable delivery systems for drugs is crucial to the pharmaceutical
industry.  In the case of neurological drugs, whose site of action is the central nervous
system (CNS), the blood brain barrier (BBB) may restrict entry into the CNS.
Designing delivery systems for the brain directed drug is therefore very important.
Various attempts have been made to develop a delivery system for drugs that are active
in the CNS.11  It was demonstrated that pentacycloundecane derived drugs, being
hydrophobic, are able to cross the BBB.6
Novel cage amino acids could therefore potentially be utilised as delivery systems,
which target the CNS when introduced into existing drugs.  Cage systems incorporated
into drugs are increasing the lipophilicity of the drugs and would promote transport of
the drug across normal cell membranes as well.10  The bulkiness of the cage system also






Amongst the forces that control protein folding and structural motifs of proteins, β-turns
comprise about 25 % of all residues in proteins and is the most important motif for
folding of proteins to produce their compact structure.12,13
A recent computational investigation has shown that the presence of cage skeletons such
as 7 and 8 have a tendency to impose a 310-helix as well as an α-helix to the polypeptide
chain.14,15,16  A promising conformational feature of cage skeletons is the fact that they
3
induce quite active β-turn characteristics.16  It is clear from the introduction above that
the availability of readily accessible amino acids with cage skeletons can open exciting
possibilities in a number of research fields, such as the modulation of the
pharmacokinetics and pharmacodynamics of pharmaceutical drugs.  The main purpose
of this investigation is to establish an improved route to synthesise the racemic PCU
amino acid (7).  An attempt to incorporate the amino acid into a non-natural peptide will
also be described.  Lastly, this investigation will attempt to apply an existing
computational model17,18 for the regioselective protection of amines and alcohols to
hydantoin systems.
4
 2. SYNTHESIS OF 8-AMINO-PENTACYCLO-
[5.4.0.02,6.03,10.05,9]UNDECANE–8-CARBOXYLIC ACID
An approach for the synthesis of the PCU amino (7) has been reported19,20.  It utilises
the easily accessible pentacyclo[5.4.0.02,6.03,10.05,9]undecane-8,11-dione (9) as the
starting material.  This approach involves the conversion of 9 to PCU monoketone (10)
which is subsequently converted to a hydantoin (11) followed by base hydrolysis to














Scheme 1: Approach for synthesis of PCU amino acid
The Diels-Alder adduct 5,8-methano-4a,5,8,8a-tetrahydro-1,4-naphthoquinone (14) is
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Scheme 2: Synthesis of PCU dione (9)
The experimental procedure of Cookson21 and Marchand22 was changed (see Chapter
6) in this study to obtain improved yields of 9.  The adduct (14) was dissolved in 10%
acetone/hexane and irradiated by direct sunlight (3-5 days).  It appears from
literature19,20,23,24,25 that the best route to obtain the PCU monoketone (10) from the
5
dione (9) is through the mono-protection of one ketone via ketal (15) formation
followed by reduction of the remaining ketone.  Ketal (15) is obtained upon refluxing
(Dean-Stark apparatus) the dione (9) with ethylene glycol in the presence of a catalytic
amount of p-toluenesulfonic acid in an azeotropic solvent such as toluene or benzene.  It
is interesting to note that according to Beilstein26 the diketal has not yet been reported.




















H O O H
H 2N N H 2
K O H , ∆∆
Scheme 3: Synthesis of PCUmonoketone (10)
Excess ethylene glycol (ratio of 1:1.5) also resulted in the formation of
pentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-11-dione-monoethyleneketal (mono-ketal,
15).  Nucleophilic attack occurs almost exclusively at the exo-face of the keto-group due











Scheme 4: Synthesis of PCU dithioketal (19)
6
Interestingly enough, the dithioketal (19) has been reported28,29 before, indicating that
the steric argument mentioned above is not so simple, as sulphur atoms are much larger
than oxygen atoms.
The next step involves reduction of the keto-ketal (15) with sodium borohydride.23,24,30
This resulted in the formation of 11-hydroxy-pentacyclo[5.4.0.02,6.03,10.05,9]-undecane-
8-one-ethylene ketal (hydroxyketal, 16).  The hydroxyketone (17) was obtained by
hydrolysing the ketal (16) group with 10% hydrochloric acid.23,24
The next synthetic step involves the reduction of the keto-functional group of the
hydroxyketone (17) to a methylene group via the modified Huang-Minlon reaction.31
Purification can be achieved by steam distillation.  After purification a quantitative yield
of mainly endo-pentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-ol (endo-PCU alcohol, 18) is
obtained.  The alcohol (18) is then oxidised using the Jones oxidation32 which employs
chromium trioxide as the oxidizing agent.  A change of colour from dark red to blue
indicates the completion of the oxidation process which results in the formation of
pentacyclo[6.3.0.02,6.03,10.05,9]undecanone ( PCU monoketone, 10).  The monoketone
(10) is obtained as a racemate.  Conversion of the ketone via the Bucherer-Bergs
















Scheme 5: Synthesis of hydantoin (11)
The hydantoin can potentially exist as two diastereomeric forms [(R)-11 and (S)-11].
Force field calculations19 showed that (R)-11 is of lower steric energy than (S)-11.  A
Density Functional Theory (DFT) calculation performed in the current study also
7
proved that (R)-11 is the more stable isomer.  The calculation was done using B3LYP
with the 6-31+g(d) as basis set.  Note that very little conformational flexibility is
possible in the rigid cage hydantoin system.  The results are presented in Table 1.  It is




















































































































































































Figure 1: (R)- and (S)- structure of PCU hydantoin (11)a
Table 1: HF energies of (S)- and (R)-PCU hydantoin
Energy /Hartree Relative Energy /kcal mol-1
(R)-PCU hydantoin [(R)-11] -763.7949808 0.0
(S)-PCU hydantoin [(S)-11] -763.7927321 1.41
Kruger19 used both Strecker and Bucherer-Bergs conditions and obtained only the
thermodynamically preferred product [(R)-11].  Norbornane (20) when treated with
Bucherer-Bergs or Strecker type reactions produces two different hydantoins, which on
hydrolysis yield the corresponding amino acids.35  The Strecker route yields the product
with the carbonyl group in the sterically more hindered position (kinetically preferred
product, 22).36
                                                
a The Cartesian coordinates of all optimized structures are available as supplementary material on














Scheme 6: Strecker route for synthesis of 22
Under Bucherer-Bergs conditions the 4'-carbonyl group of the hydantoin ring is in the














Scheme 7: Bucherer-Bergs route for synthesis of 24
However, When (+)-Camphor (25) is used under the same reaction conditions, only one

















Scheme 8: Bucherer and Strecker route for synthesis of 27
9
Steric hindrance of the nearby methyl group at the bridge carbon induces preferential
nucleophilic attack from the less sterically hindered bottom side of the carbonyl carbon.
It appears as if the PCU hydantoin exhibits similar characteristics as the Camphor











Scheme 9: Synthesis of PCU amino acid (7)
Kubik et. al.38 have utilized a facile method for the hydrolysis of α,α-disubstituted
hydantoins to obtain excellent yields of the corresponding amino acid.  The method38
introduces a Boc functional group on both the amide (N-3') and imide nitrogen (N-1') of
the α,α-disubstituted hydantoin rings to form a bis-Boc protected hydantoin.  Since the
introduced Boc group is a strong electron withdrawing group, two Boc groups
destabilise the hydantoin ring which permits a milder hydrolysis at room temperature
with lithium hydroxide, ensuring better amino acid yields.39
However, the method of Kubik et. al.38 yielded a mono-Boc protected hydantoin (28)
when applied to the PCU hydantoin system (11), as was the case with the
trishomocubane hydantoin studied by Raasch et. al.39,40  The NMR data revealed that
protection only occurred on the less nucleophilic imide (N-3') nitrogen (28) as was































Scheme 10: Synthesis of mono-Boc protected hydantoin (28)
Raasch et al39,41 argued that attachment of the Boc group to N-3' may have been forced
due to excessive steric hindrance from the bulky cage skeleton at N-1'.  The arguments
will be explored in Chapter 4 where a computational model was employed to predict
the mechanistic pathway for the regioselective acetylation of the PCU hydantoin (11).
The preferred mechanism17 of protection of amines with anhydrides involves a six
membered ring transition state (See Chapter 4, structure 65) rather than a stepwise
acyclic route.  In this cyclic transition state the leaving acetate group serves as a base to
remove the proton from the incoming nucleophile (-NH).  A cyclic transition state at N-
3' which is perpendicular to the hydantoin ring should be exposed to less steric
hindrance as compared to a similar transition state17 at N-1'.  The structural elucidation
of the novel compound (28) was made from an extensive 1H and 13C NMR
investigation.  It was evident that the mono-Boc derivative of the PCU hydantoin had
been synthesised with the appearance of three carbonyl peaks in the 13C NMR spectrum
at 146.28, 173.08 and 152.62 ppm and the appearance of the expected molecular ion
peak of m/z 329 [M+H]+ in the mass spectrum.  Further evidence for the formation of a
mono-Boc-protected hydantoin was obtained form the presence of three carbonyl peaks
11
in the IR spectrum (1718, 1765, 1803 cm-1).  The previous reported20 NMR elucidation































It was previously shown that H-4a is resonating upfield in comparison with H-4s.  The
chemical shift around 1.63-1.66 ppm can thus be allocated to H-4s and those around
1.24-1.27 ppm to H-4a.  This was also confirmed by the reported19 coupling constant of
H-4a and H-4s which is around 10.7 Hz but in this case the coupling constant was found













































































































































































Figure 2: B3LYP/6-31+g(d) Optimised mono-Boc protected PCU hydantoin
(28)
H-11s and H-1' are close enough to experience a Nuclear Overhauser Effect (NOE).19
It is therefore not surprising that the Nuclear Overhauser Effect Spectroscopy (NOESY)
indicates a strong correlation between H-11s and H-1'.   The assignment of H-4s and H-
4a helped on assigning C-4 at 34.26 ppm since it shows a HSQC correlation with both
H-4s and H-4a.  It was also previously shown19 that the coupling constants of H-11a
12
and H-11s for related but the different systems are 3.4 and 13.7 Hz respectively.  The
coupling constants were experimentally found to be 3.3 and 12.5 Hz for H-11a and H-
11s respectively.  Knowing the coupling constants of H-11a and H-11s helped with the
assignment of these protons to 1.23 and 1.43 ppm respectively.  The assignment of H-
11a and H-11s is instrumental to the assignment of C-11 to 28.07 ppm as both protons
showed HSQC correlation with C-11.  The assignment of C-11, H-11a, H-11s, C-4, H-
4a and H-4s afford dual handles for solving the rest of the structure as the rest of the
assignments can be made via various correlations with these pivotal signals.  A HMBC
correlation of H-3 and H-5 to C-4 assisted with the assignment of H-3 and H-5 to 2.33
and 2.98 ppm respectively.  H-1 and H-10 was assigned to 2.85 and 2.53 ppm
respectively due to HMBC correlation with C-11.  The presence of a proton peak (1.56
ppm) in the1H NMR spectrum, which integrated to nine protons could, therefore, be
assigned to the three methyl groups (H-8') of the t-Boc group.  The absence of the imide
proton (H-3') at about 10 ppm20 and the presence of the amide proton (H-1') at 6.02
ppm20 in the 1H NMR spectrum confirmed that the t-Boc group had attached to the
imide nitrogen (H-3').  C-5' was assigned to 146.28 ppm due the fact that it is positioned
in an electron abundant region; it is therefore expected to be more upfield in comparison
with C-4' and C-2'.  The peak at 173.08 ppm is associated with C-4' since it positioned
in electron deficient area; it is therefore expected to be a bit more downfield.  Using the
same analogy as above, C-2' was assigned to 151.56 ppm.
These values are in reasonable agreement with those obtained for the corresponding
mono-Boc protected trishomocubane hydantoin.40  The C-7' carbon of the Boc group
was assigned to 85.44 ppm in the HMBC spectrum due to correlation with the H-8'
methyl protons.  The quaternary C-8 carbon is easily recognized at 68.07 ppm as it
displays no HSQC correlation.  It is also expected to be the most downshifted carbon
owing to its direct attachment to the electron withdrawing hydantoin ring.  Carbons C-7
and C-9 were assigned at 41.60 and 49.03 ppm owing to their direct attachment to the
deshielded C-8 carbon.  At this point it was not yet possible to distinguish between C-7
and C-9; their corresponding protons are identified at 2.60 and 2.33 ppm from the
HSQC spectrum due to correlation to the two carbon atoms.  In order to distinguish
between C-7 (H-7) and C-9 (H-9) the assignment of H-5 was useful.  The H-5 proton at
13
2.98 ppm is easily recognisable from the COSY correlation with H-4s at 1.66 ppm.
Both H-7 and H-9 are HMBC correlated to C-8, and H-5 is also COSY correlated to H-
9 at 2.33 ppm.  The rest of the assignments were based on the previously reported NMR
































Table 2: NMR dataa for the mono-Boc protected hydantoin (28)



















 a400 MHz for 'H NMR and 100 MHz for 13C NMR in CDCl3
14
Similar to the approach by Raasch et al39,40,41a method by Hammer et. al 42 was used to
synthesise the novel bis-Boc protected PCU hydantoin (30).  Hammer's method is
































Scheme 11: Synthesis of PCU amino acid (7)
The NMR data of the mono-Boc protected PCU hydantoin (28) were used to elucidate
the bis-Boc derivative (30).  The successful synthesis of the bis-Boc protected PCU
hydantoin was first evident from the infrared spectrum with the presence of four
carbonyl absorption bands at 1724, 1751, 1765 and 1806 cm-1.
The aim of synthesising the bis-Boc protected hydantoin (30) is to improve the yield of
the PCU amino acid.  In this regard the bis-Boc protected hydantoin was subjected to
LiOH hydrolysis to obtain an improved yield of amino acid, but the amino acid was
contaminated with salts and di-tert-butyl imidodicarbonate (Boc2NH) so the isolation of
the amino acid proved to be difficult.  A one pot procedure was used for conversion of
bis-Boc protected hydantoin (30) to the Fmoc PCU amino acid (31).  The absence of the
amide and imide hydrogens of the hydantoin ring at about 6 and 10 ppm, respectively,
in the proton NMR spectrum confirmed bis-Boc protection.  The correct molecular ion
peak of m/z 431 [M+H]+ in the mass spectrum also confirmed formation of the bis-Boc











































Table 3: NMR dataa for bis-Boc protected hydantoin (30)






















                                              a400 MHz for 'H NMR and 100 MHz for 13C NMR in CDCl3
16
The presence of two methyl peaks in the proton NMR spectrum which integrate to nine
protons (H-12') is typical of the Boc functional groups.  The 13C NMR spectrum
exhibits four carbonyl groups.  Two-dimensional NMR techniques were essential for the
full elucidation of 30.  H-12' and H-8' were assigned to 1.543 and 1.519 ppm owing to
HSQC correlation with C-12' and C-8' respectively. The assignments for the bis-Boc
hydantoin are presented in Table 3.
To overcome the difficulties mentioned above, the cleavage reaction mixture was
extracted with ether to remove Boc2NH while the amino acid (7) stayed in the aqueous
layer as the lithium salt.  Fmoc-Cl was added to the reaction mixture while the pH was
adjusted to 6.5 and a quantitative yield of Fmoc PCU amino acid (31) was obtained.
Evidence of the successful synthesis of the Fmoc PCU amino acid (31)43 was obtained
from MS (correct molecular ion peak of m/z 431 IR and NMR data).
The attempted coupling of the sterically hindered PCU amino acid to non-natural
peptides is discussed on the next chapter (Chapter 3).  In order to improve the chances
of a successful coupling of the PCU amino acid to a peptide the more active acid halide
(32) is required.  The use of the relatively stable acid fluorides has been reported to
ensure successful coupling of sterically hindered amino acids.44,45  The application of
acid chlorides has been introduced but it has shown a lot of disadvantages due to the
fact that N-protected amino acid chlorides are relatively unstable due to their high
reactivity and sensitivity to hydrolysis.46,47  The preparation of stable Fmoc protected
trifunctional amino acid chlorides showed similar difficulties.48  Acid fluorides exhibit
sufficient reactivity partly due to the smaller size of the fluoride leaving group when
compared to acid chlorides.47  It was therefore decided to synthesise the Fmoc PCU
amino acid fluoride (32).43  The synthesis involved the mixing of Fmoc PCU amino
acid, cyanuric fluoride and dry pyridine in dry dichloromethane at room
temperature.43,49  The removal of the organic solvent and recrystallisation in























Scheme 12: Synthesis of Fmoc PCU amino acid flouride (32)
Acid fluorides are stable and can be stored for up to six months under normal
conditions.  A further benefit of acid fluorides is the absence of oxazolone formation as
coupling is performed in the presence of a base.50  The acid fluorides have proven to be
effective in the coupling of sterically hindered amino acids such Aib into short
peptides.47
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 3. SOLID PHASE PEPTIDE SYNTHESIS (SPPS)
Naturally occurring peptides are known as biopolymers or proteins.  Proteins are basic
constituents of all living organisms.51  Their central role was recognised in the early 19th
century when the name of these molecules was coined from the Greek word, Proteios,
meaning “holding the first place”.52  Proteins are natural polymers (34) built from
naturally occurring α-amino acids and the backbone of the protein consists of a
continuous amide (33) chain.
      34 Polyamide
33 Amide 









The twenty common amino acids contain at least one chiral centre, except for the
achiral glycine (H2N-CH2-COOH).
53  The twenty common naturally occurring α-amino






Since the hydrogen atom always has the lowest priority according to the Cahn-Ingold-
Prelog rules, followed by the side chain (R-group), acid group and lastly the amine
group which possesses the highest priority, most of the twenty common naturally amino
acids have the (S)-configuration.54  Cysteine is only exception as the side chain contains
a sulphur atom, which has a higher priority than the oxygen on the acid function.
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The covalent amide bond that joins amino acids together in a condensation reaction is
called a peptide bond (36).55  The peptide bond (36 and 37) is formed between the α-
amino group of one amino acid and the α-carboxyl group of another amino acid.  The
bond has an unusual property that has a marked effect on the rigidity of a polypeptide
chain and consequently on the folding of the polypeptide chain.  It has partial double
bond character (36 and 37), which is caused by delocalization of the nitrogen lone pair






















Scheme 13: Peptide bond
The consequence of this arrangement is that the peptide bond is relatively rigid with the
hydrogen atom in a trans position with respect to the carbonyl oxygen.  The net result is
that the six atoms around the peptide bond all lie in a plane i.e. the peptide bond
“freezes” 6 atoms in a planar state because the C-N bond exhibits partial double bond
character.  This means that free rotation in peptides is under normal conditions only
possible at the bonds adjacent to the peptide bonds.  These bonds are defined by the phi
(ψ) and psi (φ) angles14,56 (38).  The amount of rotation possible and therefore the
values of ψ and φ depend on the particular side chain (R-group) of the amino acids that
are joined together.  This free rotation gives rise to unique conformational structure of
proteins which is an important prerequisite to understanding conformational
characteristics of peptides.14,16,56  The accessible conformational space of an amino acid
residue can essentially be characterized by its potential energy map, often referred to as the
Ramachandran map.57  These maps are generated from systematic rotation of the backbone
torsion angles, φ and ψ (38) defined by the N-C and C-C bonds, respectively.  Glycine is
the most flexible amino acid residue, accessing more than 60% of the conformational
space.58  In contrast, proline is the only natural amino acid residue with its accessible
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conformational space considerably reduced.59  Biopolymers or peptides are considered to









Figure 3: Phi (ψ) and psi (φ) angles14
Each specific receptor site of viral or bacterial affected areas possesses a certain 3-
dimensional structure which interacts with the pharmaceutical drug.61  The mechanism
of drug and receptor interaction is sometimes called the key and lock, or hand and glove
mechanism.  One of the most relevant aspects of synthesizing peptides is therefore to
combine a limited set of amino acids in a well defined sequence.  During the synthesis
of the peptide, the peptide molecules arrange themselves into a conformational folder
called a foldamer a name which was first coined by Gellman.60  The structural
conformation, such as α-helix, β-sheets and β-turns of the peptide, is an important
fixture for designing the best synthetic proteins62 and the three dimensional structures
also serve as the backbone when interacting with target or receptors sites.61
Without these conformational structures, it is quite difficult to make general useful rules
about the structure and functions of peptides.  It is therefore not surprising that research
to determine the driving force for the folding process or for the formation of the
secondary and tertiary structure of proteins has been the aim of many researchers.14,16,63
If this secret is revealed it might be possible to predict the structural functions of
peptides.  Studies have revealed that β-turns (39) are the most predominant structural
conformations that are used in determining the proper functions of the protein chains.55
These conformational motifs occur to a great extent in globular proteins and in the
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membrane-active, channel-forming peptide antibiotics.64  The intramolecular hydrogen
bonding adopted by an amide group depends most on the steric hindrance of the R-
group.
β-Turns (39) constitute a significant secondary structural component within peptides
and proteins.  These conformations differ by the orientation of the amide bond






















Figure 4: A typical β-turn56
The β-turns (39) comprise about 25 % of all residues in proteins and also are the most
important motif for folding of proteins to produce their compact structure.12,13,14  The
criteria for defining a β-turn are widely accepted.56,65,66
The first synthetic peptide was introduced by Emil Fischer.52  Peptide synthesis made
use of solution chemistry in the early stages of peptide research.  Solution phase peptide
synthesis encountered problems with solubility and purification.  The versatile solid
phase peptide synthesis (SPPS) was first introduced by Merrifield in 1963.67  Solid
phase peptide synthesis strategy with the temporal base labile α-amino protecting group
(Fmoc) was introduced by Carpino in 1972.68  General speaking in Fmoc SPPS, the α-
amino group is protected by Fmoc and the side chain functional groups are protected by
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the acid labile t-butyl type protecting group.  Fmoc based SPPS provides an alternative
method to the t-Boc SPPS and offers the advantage of milder acidic cleavage processes
during the deprotection of the Fmoc group.  The development in Fmoc SPPS can be
summarized in the following categories: solid support, linkers, attachment of the first
residue, protecting groups, Fmoc deprotection, coupling reagents, monitoring, cleavage
and removal of the protecting groups, peptide evaluation and peptide modification.69
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Scheme 14: Deprotection mechanism with piperidine
SPPS requires a well solvated gel to allow the reactions to take place between reagents
in the mobile phase and functional groups on the chains attached to the resin.  The first
polyamide resin was introduced by Atherton70 under the concept that the solid support
and the peptide backbone should be of comparable polarities.  Recent developments
make use of resins based on grafting of polyethylene glycol (PEG) to low crossed linked
polystyrene which led on the development of resins such as Tentagel.71  4-
Methylbenzhydrylamine resin (MBHA, 0.7 mmol NH2/g , 44) has shown excellent
swelling capacity and superior performance especially when manual peptide synthetic
procedures are employed.40
The function of the linker is to provide a reversible linkage between the peptide chain
and the solid support, and to protect the C-terminal of the α-carboxylic group.  The
linker should be stable to the reaction conditions employed and should be cleavable (to
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There has been much success with the use of (p-[(R,S)-α-[1-(9H-fluoren-9-yl)methoxy-
formamido]-2,4-dimethyl-benzyl]-phenoxyacetic acid (FmocAM linker, 45) as it is














With the fmoc PCU amino acid fluoride (32)43 (see Chapter 2), an attempt was made to
synthesise the proposed tetrapeptide (46).  This tetrapeptide (46) would be the first step























As mentioned above, the synthesis of peptides involves a series of steps therefore a
number of peptides were synthesised using SPPS in order to gain insight and hands-on
experience with SPPS techniques.  The first attempted peptide was the pentapeptide
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(ala-ala-ala-ala-ala, 47).  The synthesis of 47 required attachment of the linker 45 to the




























The synthesis was performed using the 4-methylbenzhydrylamine resin (44) in DMF.
Coupling of the linker was achieved by the addition of the in situ coupling reagents 1-
hydroxybenzotriazole (HOBt, 48) and the dehydration agent diisopropyl carbodiimide











The Fmoc group of the linker was removed by treatment of the resin with 20%
piperidine in DMF.75  The removal of the Fmoc group was confirmed by a positive
Kaiser test.76  This was followed by the successively coupling of the five alanine
“layers” in the presence of 48 and 49.  The outlined mechanism (Scheme 15) shows that
during the synthesis of peptides, the in situ reagent 49 acts as the dehydration agent
which leads to the formation of urea. It also activates the acid functional group of the
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Scheme 15: Dehydration mechanism with DIPCDI and HOBt
The excess reagents were removed by washing with DMF and isopropanol.  The
pentapeptide (47) was prepared for cleavage by washing successively with
dichloromethane, methanol and diethyl ether, followed by drying in vacuo.77  The
cleavage mixture of 95 % (v/v) trifluoroacetic acid, 2.5 % (v/v) water and 2.5 % (v/v)
triisopropylsilane was subsequently added.77  Triisopropylsilane serves as a carbocation
scavenger.  The resin (44) was removed by filtration, the filtrate was centrifuged
followed by the application of nitrogen gas to remove most of the TFA.
Diethyl ether was subsequently added to precipitate the peptide from the solution.
Decanting the diethyl ether after separation through centrifuging served to separate the
linker and triisopropylsilane (60) from the peptide.77  As it can be seen in the cleavage
mechanism (Scheme 16), a peptide amide (58) is formed when the linker 45 is
employed.  Triisopropylsilane reacts with the linker to form 60 which is soluble in
diethyl ether and it is therefore decanted while the resin is filtered out.
Triisopropylsilane is therefore called a scavenger as it is assisting with the removal of
unwanted and reactive carbocation side-products during the cleavage process.
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Scheme 16: Mechanism for cleavage of peptide
The successful synthesis of the pentapeptide (47) was verified by IR, NMR and HPLC.
It was evident that 47 had been synthesised with the appearance of five carbonyl peaks
in the 13C NMR spectrum at 174.1, 172.0, 171.7, 171.6, 169.3 ppm.  The appearance of
the expected molecular ion peak of m/z 372 [M+H]+ in the mass spectrum also
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confirmed the formation of the pentapeptide.  Further evidence for the formation of the
pentapeptide (47) was obtained from the presence of five carbonyl peaks in the IR
spectrum (1703, 1683, 1663, 1630, 1545 cm-1).  The five carbon peaks in 13C NMR at
18.6, 18.4, 18.3, 18.2 and 17.4 ppm were associated with five methyl groups present,
one for each alanine.  The purity of 47 was also determined with High Performance
Liquid Chromatograph (HPLC) which gave two peaks.  The first peak at the retention
time (RT) of 5.85 min. corresponds to 47 the purity was calculated to be 94.2% and the
second unidentified peak appeared at 10.3 min.
From Scheme 16 it can be concluded that 46 and 47 are the expected peptides when the
synthesis is done in the presence of the linker 45.  The synthesis of the proposed Cage
tetrapeptide (46) involved the synthesis of resin-bound tripeptide (61) following by the
coupling method presented above.  A small amount of 61 was cleaved from the resin to
verify the purity of the tripeptide with HPLC analysisb only one peak was obtained























 61 Resin bound tripeptide
The Fmoc PCU amino acid fluoride (32) was added to the resin-bound tripeptide along
with DMF and pyridine as a fluoride ion scavenger.49  This was necessary since
hydrofluoric acid is effective in cleaving MBHA linkages.78  The successful addition
was confirmed by a negative Kaiser test.  The Fmoc group was removed by addition of
20 % (v/v) piperidine in DMF.77  A positive Kaiser test was obtained.  The cage
tetrapeptide was prepared as described above.  The purity of the tetrapeptide (46) was
                                                
b The details of the HPCL conditions are provided in the experimental section.
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confirmed using HPLC analysis.  The HPLC spectrum clearly reveals that the PCU
amino acid was not completely coupled to the tripeptide as it reveals a peak at 3.61 min.
which represents the presence of tripeptide.  The tetrapeptide (46) peak appeared at 14.9
min and the calculated purity of 46 was 67.6 %.  Full elucidation of the tetrapeptide was
not achieved as an effective separation of the peptides was not achieved with the limited
amounts available.  The proton NMR analysis of the tetrapeptide was performed and
confirmed the presence of the PCU amino acid.  NMR analysis of the peptide confirmed
the removal of the Fmoc protecting group.  The IR, proton NMR and HPLC were used
to verify the structure of the tetrapeptide.  The presence of the four carbonyl peaks at
1752, 1677, 1622, 1547 cm-1 in the IR spectra confirmed that the tetrapeptide was
successfully synthesised.  The molecular ion peak of m/z 419 [M+H]+ in the mass
spectrum also confirmed the formation of the tetrapeptide (46).  The proton NMR
analysis clearly indicated three methyl groups which were indicating the presence of
three alanines.  The intensities of the proton peaks are in agreement with the cage peaks,
indicating that the tripeptide was in fact coupled to the cage amino acid.
The pentapeptide (47) and tetrapeptide (46) were successfully synthesised according to
spectrometric results given.  The tetrapeptide proved difficult to purify, and
consequently a full structural elucidation by NMR techniques was not possible.  It is of
great importance and interest that further study is conducted to synthesise the peptide in
purer form or to purify the peptide using preparative HPLC.
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 4. COMPUTATIONAL CHEMISTRY
4.1. Introduction
The acetylation of the PCU hydantoin (see Chapter 2) initiated the computational
investigation as the distribution of the products obtained were different to results
obtained with basic hydantoin systems.79,80,81  Computational chemistry can provide
one with energetic data about the energy barriers involved between reactants and
products, as well as the relative energies of the intermediates and products.82  The
energy barriers between reactants and products provide insight about the kinetics of the
reaction and the relative energies of the products and intermediates provide insight
about the thermodynamics of the reaction.  When two or more competing reactions are
possible, one might be able to use a computational model to determine which pathway
will be kinetically and/or thermodynamically favoured.  The most difficult part of this
investigation is to determine the energy barriers involved in the reaction.  In order to
determine the energy barrier involved, one has to find the transition state structure,
which connects the reactants to the products.  More information about this aspect will
be provided below.
Computational chemistry can also provide valuable spectroscopic (IR, UV, NMR) data
of structures under investigation.  Another application is to calculate the energies and
shapes of various orbitals (such as the HOMO and LUMO) and electron densities of
molecules.  There are two broad areas within computational chemistry devoted to the
structure of molecules and their reactivity: molecular mechanics and electronic
structure theory.  Both fields involve the same basic types of calculation used in this
investigation:
• Computing the energy of a particular molecular structure.  Properties related to
the energy may also be estimated.
• Performing geometry optimisations, which locate the lowest energy molecular
structure nearest to the specified starting structure.
• Computing the vibrational frequencies of molecules.
Molecular mechanics simulations use the laws of classical physics to predict the
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structures and the properties of molecules.82,83  There are many types of methods of
calculation.  Each one is characterised by a particular force field.  Force fields have the
following components:83
• A set of equations defining how the potential energy of a molecule varies with
the location of its components.
• A series of atom types which define the characteristics of an element within a
specific chemical context.
• One or more parameter sets that fit the equations and the atom types to the
experimental data.  The parameter sets are the force constants which are used in
the equations to relate atomic characteristics to energy components and to the
structural data such as bond length and angles.
• Each force field achieves good results only for molecules related to those for
which it was parameterised.
Molecular mechanics calculations do not explicitly treat the electrons in a molecular
system but perform calculations based on the interactions among the nuclei.  The
electronic effects are implicitly included in the force field through parameterisation.
This approximation makes the molecular mechanics computations quite inexpensive
with respect to computing time.  However, the approximation also carries several
limitations, the most important of which are:84
• Molecular mechanics methods cannot treat chemical problems where electronic
effects predominate because it neglects the presence of electrons
• Electronic methods use the laws of quantum mechanics rather than classical
physics as the basis for their computations.  Quantum mechanics state that the
energy and other related properties of a molecule may be obtained by solving the
Schrödinger equation.
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There are two classes of electronic structure methods:82
• Semi-empirical methods such as AM1, MINDO/3 and PM3 which are
implemented in programs like MOPAC, AMPAC, HyperChem and Gaussian.
These methods use parameters derived from experimental data to simplify the
computation through quite severe approximations.
• Ab initio methods, unlike molecular mechanics or semi-empirical methods, do
not use experimental parameters such as bond lengths, angles etc. in their
calculations.82  Instead computations are based on the laws of quantum
mechanics, the first principle which is referred to the name ab initio and is based
on the values of a small number of physical constants such as the speed of light,
Planck’s constant, the masses and the charges of nuclei and electrons.
• Semi-empirical and ab initio methods differ in the trade-off made between
computational cost and accuracy of results.  Semi-empirical calculations are
relatively inexpensive and provide reasonable qualitative descriptions of
molecular systems and fairly accurate prediction of energies and structures for
systems where good parameter sets exist.  Semi-empirical methods are therefore
not well equipped to deal with most novel transition states as no parameters for
these systems exist.  In contrast ab initio computations provide high quality
quantitative predictions for a broad range of systems.
Density functional theory (DFT)85 is the third class of electronic structure methods
which has become very popular recently.  It is similar to ab initio methods and it
requires about the same amount of computational resources as Hartree-Fock theory
which is the least expensive ab initio method.  The DFT methods are attractive because
they approximate the effects of electron correlation where electrons in a molecular
system react with each other’s motion in an attempt to keep out of each other’s way.
DFT methods only approximate the effect of electron correlation as the derivation of
suitable formulae for the exchange correlation term depends on a solution to a function
which is not exactly known.85
DFT methods are based on the theory by Hohenberg and Kohn86,87 in which they
demonstrated that the ground state energy of any molecule can be described in terms of
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the total electron density which means that each molecule has an unique functional form
which exactly determines the ground state energy and electron density of the molecule.
The Hartree-Fock calculations consider this effect only in an average sense.88  These
approximations cause Hartree-Fock results to be less accurate for some types of
systems.  Thus, DFT methods can provide the benefits of some more expensive ab initio
methods (electron correlation methods such as MP2) at essentially the cost of a Hartree-
Fock calculation.89  The Gaussian90 software offers the entire range of electronic
structure methods.  This study relies on the application of DFT methods as they provide
the most reliable ways for doing calculations at a reasonable level of theory.  DFT
methods have disadvantages as the precise function is not known and the reason for the
relatively good accuracy of result is not exactly known.85,86,87  The practical problem
that theoreticians have with DFT is that one is not able to approach the real solution of
the wavefunction, as is the case with ab initio methods, by increasing the level of theory
and the type of the basis set.88
The methods and aspects discussed above [Molecular Mechanics, Semi-empirical, ab
initio (RHF and MP2) and Density Functional Theory] are commonly called the “level
of theory” applied to calculate the geometry and energy of a molecule.  Both ab initio
and DFT are concerned with predicting various properties of atomic and molecular
systems.  The current investigation depended heavily on transtion state calculations and
was limited to RHF and DFT caluations.
The references below discuss important aspects which should be considered when one is
using computational methods:
• The Schrödinger equation88
• The Born-Oppenheimer approximation of the Schrödinger equation.91
• The Hartree-Fock approximation.88
• Linear Combination of Atomic Orbitals (LCAO) approximation.82
• Roothaan-Hall equations.82
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4.2. Restricted Hartree-Fock (RHF) vs Unrestricted Hartree-Fock
(UHF)
The Hartree-Fock wave function, in which the electron spins are by default paired and
also occupy the same spatial orbital, is called a Restricted Hartree-Fock (RHF)
wavefunction.  This kind of Hartree-Fock wave function is derived from molecular
orbital occupation of electrons which give rise to a wave function of singlet type.
Unrestricted Hartree-Fock wave functions are those that occur when the α-electrons
are allowed to differ from those of spin-β-electrons.  The difference between these wave
functions is that the former method uses a reasonable approximation while the latter is
computationally cumbersome but provides superior results for certain system.83,85
4.3. Basis sets
Molecular orbitals can be expanded as a linear combination of atomic orbitals and are
then called basis functions.83,85  The basis functions are collectively called basis sets.








where, Cµi = molecular orbital expansion coefficient, and φµ = basis function of atomic
orbital.
There are two ways in which the basis set can be explained.83  The first is to think of a
basis set as the atomic orbital in the qualitative molecular orbital.  The second is to think
of the basis set as a group of mathematical functions which are designed to give the
maximum flexibility to the molecular orbital.  However the system must include basis
sets that really count for something and poor basis sets must be excluded since they
increase the cost of calculation for no gain.  There are different kinds of basis sets which
are discussed in the following sections.
34
4.3.1. Minimal basis set93
The essential idea about the minimal basis set is that one basis function is selected for
every atomic orbital that is required to describe the free atom.  Several minimal basis
sets which are commonly used are the STO-nG basis sets.  The most common minimal
basis set is called STO-3G, where a linear combination of three Gaussian type atomic
orbitals (GTO-type) are fitted into Slater-type atomic orbitals (STO).88  The individual
GTOs are called primitive orbitals, while the combined functions is called contracted
functions.  Some commonly used STO-nG basis are STO-4G and STO-6G where STO
is fitted onto 4 and 6 GTOs respectively.
4.3.2. Split-valence basis sets93
These are the 3-21G basis set where the valence functions are split into one basis set
with two GTOs and one with one GTO, the 6-31G basis set where the core consists of 6
GTOs which are not split, while the valence orbitals are described by one orbital
constructed from three primitive GTOs and one that is a single GTO.
4.3.3. Double zeta (DZ) basis sets93
In these basis sets, every member of the minimal basis set is replaced by two functions.
For some heavier atoms DZ basis sets may double the number of minimal basis set
orbitals.
4.3.4. Polarisation basis sets93
It was argued that the orbital on an atom becomes smaller in a molecule because of the
attraction of the other nucleus.  However, it is clear that the other nucleus will only
distort or polarize the electron density near the nucleus.  This is done in the presence of
orbitals with more flexibilities and is accomplished by addition of a basis function of
higher angular momentum quantum number.  Figure 5 shows that the 1s orbital of
hydrogen can be distorted by mixing with an orbital of p symmetry.  It is therefore said
the orbital has been polarized.
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+
Figure 5: Polarization of a s-orbital
Similarly the p orbitals can be polarized as follows:
+
Figure 6: polarization of a p-orbital
These additions of the basis set are called polarization functions.  The most common
polarization basis sets are 6-31G* which adds the d-functions to the atoms and 6-31G**
which adds d-function and one type d-function to hydrogen.  The modern nomenclature
of these basis set has been changed to 6-31G(d) and 6-31G(d,p) respectively.  Similarly
the basis set can be expanded to 6-31G(3df,pd) which adds 3d-type, 1f-type and one
type d-functions.  Polarization functions remove some limitations of the basis sets by
expansion of the virtual space of the orbital.
4.3.5. Diffuse basis set functions
In some cases the normal basis sets described above are inadequate.  This is particularly
in the case of excited states and in anions where the electron density is more spread out
over the molecule (i.e delocalization).  To correct this, a model basis function was
designed which is more “spread out”.  This additional “spreading out” of the basis
function is called diffuse functions.93
Diffuse functions are represented as the “+” in the basis set, for example 6-31+G which
adds a set of diffuse s- and p-orbitals to atoms.  The basis set 6-31++G adds a sets of
diffuse s-, p-orbitals to the atoms and a set of diffuse s-function to the hydrogen.
Diffuse functions can also be used in the presence of polarization functions and the basis
sets are then represented as follows: 6-31+G(d), 6-31+G(d,p) and 6-31G(3df,pd) or 6-
31G++(3df,pd).
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The size of the current problem is similar to that previously studied,18 a similar basis set
[6-31+G(d)] was therefore used.  This basis set produces almost the same geometries
and relative energies as were obtained when performing17 these optimisations with the
additional polarization functions on hydrogen atoms.  Diffuse functions are typically
used as a better treatment for cases where negatively charged species are being studied
because the ionic radius of an anion is significantly bigger than the corresponding
neutral species.  In the present case, using diffuse functions on only heavy atoms is
justified because the negative charge is mainly located on the oxygen and nitrogen
atoms.
4.4. Practical Considerations for Computational Chemistry
Quantum chemical models open a range of possibilities for synthetic organic chemists
wishing to anticipate the distribution of the products in kinetically controlled reactions.
Experimentally, it has now become possible to examine reaction mechanisms including
transition states directly using femtosecond pulsed laser spectroscopy.94  However, it
will be some time before these techniques can be applied to all of the compounds that
are accessible computationally.  Furthermore, these techniques yield indirect








Synthetic approaches to obtain information about transition-states are also limited to
very special cases, such as the static SN2 transition-state 62 shown above.
95  An X-ray
structure of 62 was reported.95
A lot of information can be obtained when the results of the kinetically controlled
37
reaction is compared to the energies of the transition states leading to the formation of
different intermediates or products.  The observed product will pass through the
transition with the lowest energy.  One of the interests of chemists is to determine the
stability of the products formed.  The relative stability of the products is indicated on the












Figure 7: Stages on a simple reaction coordinate96
The differences in energies between reactants and intermediates or products represent
the thermodynamic nature of the reaction.  The most common reaction has the energy of
the products lower than that of the reactants.  Such reactions could be spontaneous
provided that the energy barrier (transition state) between the reactants and products are
not too high.  In such a case the reaction is called an exothermic reaction (see Figure 8).
In cases where the free energy of the product is higher than that of the reactant the
reaction is said to be endothermic and energy will have to be “pumped” into the system
to obtain the endothermic product.  The same is true for cases where the energy barrier
(transition state or activation energy) is too high (> 15 – 20 kcal mol-1)97 to be overcome
at room temperature.
According to the diagram (Figure 8) product C is more stable than B, and C is also
kinetically preferred as it passes through a transition state with lower energy.  The










Figure 8: Kinetically and thermodynamically preferred reaction96









Figure 9: Kinetically preferred reaction96
It was hoped that a computational model17,18 would be able to predict the regioselective
protection of hydantoins with anhydrides.  Calculations to determine the energies of
reagents, transition states and products might shine some light on the mechanism of the
reaction especially since regioselective protection of the hydantoins at either N-1' or N-
3' is possible (see Chapter 2 and 5).
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4.5 Computational Considerations and Details
Ab initio gas phase calculations were done with Gaussian 0390 at the DFT
(B3LYP)98,99,100 level of theory with the 6-31+G(d) basis set.  Solvation and catalytic
effects were not considered in order to simplify the model.  The model was further
simplified by using acetic anhydride in the calculations instead of t-Boc anhydride.  It
was previously shown17 that the model system also holds for sterically hindered
anhydrides such as t-Boc anhydride.
Geometry optimizations were performed without restrictions in order to locate extrema
presented herein (Table 4).  Transition states were characterized by a single imaginary
frequency which corresponds to the movement of atoms consistent with the expected
reaction.
In some cases the animation of the atoms associated with the imaginary frequency
might not be clearly associated with the expected transition state.  An Intrinsic Reaction
Coordinate (IRC) calculation should then be performed to see if the transition will yield
the known reagents and products, i.e. the reactants and products are indeed connected
through the specific transition.93  This procedure is unfortunately very expensive in
computer time, as a frequency calculation is performed between each forward and
backward step.  All transition states found in this study were characterised using
second-derivative vibrational frequency calculations.  A computational model for the
regioselective protection of alcohols, amines and lactam nitrogens was recently
postulated.17,18  The model also neglected solvent and catalytic effects and suggested
that the protection of OH and NH groups in the “gas phase” proceed through a unique
cyclic 6-membered ring transition state (see Scheme 17).
The cyclic transition states seem to belong to the same class of pseudopericyclic
transition states reported before.101,102,103  It is beyond the scope of this investigation to
determine the similarities and differences between those pseudopericyclic transition
states and the cyclic transition states reported herein.
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Scheme 17: Theoretical stepwise (66) vs. cyclic (64) transition states
The intermediate 67 is not a minimum on the potential energy surface [B3LYP/6-
31+G(d)], which illustrates the need for the solvent or a base to remove the proton from
the incoming nucleophile.  In reality the acyclic route would certainly also occur
experimentally, but then almost, if not completely, as a concerted reaction where the
solvent (base) would remove the proton from the incoming nucleophile as an effective
collision forges bond formation/breaking as suggested in Scheme 17.  It is expected that
the same regional steric factors would be experienced by both the cyclic and acyclic
routes, although the cyclic transition state (65) is likely to experience an amplified steric
effect due to the nature17,18 of the 3-dimensional structure of the cyclic transition state.
The calculation was successfully applied to the pentacycloundecane cage lactam
system.18  Acetylation of the lactam could potentially lead to four different structural


























































Figure 10: Possible acetylation products of the a δ-lactam18
The calculation18 indicated that 71a is both thermodynamically and kinetically preferred
which correlates with the experimentally observed product.  As part of an extended
project to synthesise cage amino acid derivatives,20,39,41,104,105,106 a number of cage
hydantoins have been synthesized.  The applicability of the computational model was
applied to three different hydantoin systems, namely 5-methylhydantoin (72), 5,5-




























Figure 11: Protection of hydantoins: N-1' versus N-3'
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4.6. Synthetic results and considerations
According to Beilstein107 protection of 5-methylhydantoin (72) with acetic anhydride
occurs at N-179 while protection of 5,5-dimethylhydantoin (73) occurs at either N-179,81
or N-3.33,108  On closer inspection of the original papers, it appears81 as if the initial
mono-acetyl protected 5,5-dimethylhydantoins were confused; protection occurs at N-1’
while the second product is rather the 5,5-dimethylhydantoin-2-enolacetate.
It was also discovered that the mono-Boc protection of 72 and 73 have not yet been
reported and attempts to synthesise them will be reported.  In a concurrent study,41 it
was found that the trishomocubane hydantoin is selectively protected at N-3'.  It appears
as if competition between N-1' (more steric hindrance but stronger nucleophile) and N-
3' (less steric hindrance but less nucleophilic) influence the course of the reaction.  It
was previously shown18 that chiral alcohols and amines form diasteriomeric transition
































Figure 12: Chiral diasteriomeric transition states for a chiral amine.
Note that both transition states lead to the same product.  In the case of a chiral
hydantoin (or lactam) with a non-equivalent “top” and “bottom” side, two more























































































































































































































































































































































































































































































































































































































































Figure 13: Four pairs of diastereomeric transition states for 5-methyl hydantoin
(72) with acetic anhydride [B3LYP/6-31+g(d) optimized]c
                                                
c Cartesian coordinates of the structures are available as supplementary material on the CD
attached to the thesis.
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The same holds for transition states leading to the cage hydantoin (11).  The more




































































































































































































































































































































































(S)-TS – N-1' (S)-TS- N-3'
Figure 14: Two pairs of diastereomeric transition states for 5.5-dimethyl
hydantoin (73) with acetic anhydride [B3LYP/6-31+g(d) optimized]c.
The three hydantoins (11, 72 and 73) were protected with t-Boc anhydride at room
temperature under stoichiometric controlled conditions (1:1).  The mono-Boc protected
hydantoins were isolated and the structures elucidated with normal analytical
techniques.
4.7. Discussion of the computational and experimental results
As was the case for the PCU lactam, precomplexes109 between the hydantoin and acetic
anhydride could not be obtained for most of the systems.  The computational results for
the more symmetric 5,5-dimethylhydantoin (73) are presented in Table 4.
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Table 4: Relative energiesa for 5.5-dimethylhydantoin (73)
Relative energies (kcal mol-1)
(S)-TS – N-1' (R)-TS- N-1' (S)-TS- N-3' (R)-TS-N-3'
∆EA 4.5 4.8 7.6 7.6
∆Hproducts -21.8 1.8
a
Relative to reactants – B3LYP/6-31+G(d)
The same cyclic transition state was obtained for all three hydantoin compounds, both at
the N-1' and N-3' position.  The experimentally observed product 1-Ac-5,5-dimethyl
hydantoin (76)81 is the kinetically and thermodynamically preferred product according

























































































































































Figure 15: Three possible products for acetylation of 5.5-dimethyl hydantoin
(73) with acetic anhydride [B3lyp/6-31+g(d)]d
The computational results also confirmed the conclusion by Salmon and Kozlowski,81
namely that upon heating other products such as 5,5-dimethylhydantoin-2-enolacetate
(78) only the thermodynamically preferred product (1-Ac-5,5-dimethyl hydantoin, 76)
is obtained.  They have also found that under thermodynamic conditions, protection at
N-1 occurs exclusively.  The experiment in the current study was performed at room
temperature and according to the 1H NMR spectrum, a small percentage of 3-Ac-5,5-
dimethyl hydantoin [77 (~25%)] had also been formed (see Chapter 5).
                                                
d Cartesian coordinates of the structures are available as supplementary material on the CD





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 16: Four pairs of diastereomeric transition states for the PCU hydantoin
(11) with acetic anhydride [B3LYP/6-31+g(d) optimized].e
                                                
e Cartesian coordinates of the structures are available as supplementary material on the CD
attached to the thesis.
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The kinetic data in Table 4 suggests that both N-1' and N-3' should in principle be
protected at room temperature as molecules have enough thermal and kinetic energy at
room temperature to allow processes requiring between 15 to 20 kcal/mol.97  However,
the rule of thumb93 is that a difference of about 1 kcal mol-1 in activation energy should
result in a 90:10 ratio of possible products.  The calculated difference of 2.8 kcal mol-1
between the transition states indicates a much larger regioselectivity than was obtained
experimentally.  The discrepancy between the theoretical and experimental results
might be due the fact that a smaller anhydride (acetic anhydride) was used in the
computational model, while a larger anhydride (t-Boc anhydride) was used in the actual
experiment (see Chapter 6).  Furthermore kinetic data represent only part of the whole
picture as entropy is also playing a role.  The calculated energies for the 5-
methylhydantoin (72) and PCU hydantoin (11) systems are reported in Table 5.
Table 5: Relativea energies of transition states and products b
5-methylhydantoin (11) kcal mol-1
Pentacycloundecane (PCU)
hydantoin (13) kcal mol-1
(S,R)-TS-top-N-1' -1.4 (R,R)-TS-top-N-1' 23.0
(S,R)-TS-bot-N- 1' 10.8 (R,R)-TS-bot-N-1' 40.4
(S,S)-TS-top-N-1' 4.6 (R,S)-TS-top-N-1' 24.3
(S,S)-TS-bot-N-1' 3.9 (R,S)-TS-bot-N-1' 35.3
(S,R)-TS-top-N-3' 7.8 (R,R)-TS-top-N-3' 21.5
(S,R)-TS-bot-N-3' 7.8 (R,R)-TS-bot-N-3' 20.5
(S,S)-TS-top-N-3' 7.2 (R,S)-TS-top-N-3' 20.6
(S,S)-TS-bot-N-3' 7.2 (R,S)-TS-bot-N-3' 21.3
Products Products
N-1'-Ac (79) -0.1 N-1'-Ac (81) 2.4
N-3'-Ac (80) 1.1 N-3'-Ac (82) 0.4
a Relative to reactants – B3LYP/6-31+G(d)
b Cartesian coordinates of the structures are available as supplementary material on the
CD attached to the thesis.
The calculated relative energies suggest that 1-acetyl-5-methylhydantoin (79) is both
kinetically and thermodynamically preferred.  The kinetic difference is about 8.6 kcal
mol-1 in favour of protection at N-1'.  The experimental was performed at room
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temperature and 1-t-Boc-5-methylhydantoin (79) was exclusively obtained (see
Chapter 5).  The much higher energies for (R,R)-TS-bot-N-1' (40.4 kcal mol-1) and
(R,S)-TS-bot-N-1' (35.3 kcal mol-1) is the result of steric repulsion between the
incoming carbonyl group and the CH2 (C-11) group of the rigid cyclohexane boat
structure of the PCU hydantoin (see Figure 16).  It is clear that the larger steric
hindrance imposed by the rigid PCU skeleton is forcing protection away from the



















































































































































































































































































































































Figure 17: Four products for acetylation of PCU hydantoin (11) and 5-methyl
hydantoin (72) with acetic anhydride [B3LYP/6-31+g(d) optimized]f
                                                
f Cartesian coordinates of the structures are available as supplementary material on the CD
attached to the thesis.
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Protection of the PCU hydantoin (11) with anhydride occurs at N-3' (see Chapter 2).
The theoretical results imply that protection at N-3' is kinetically (1.5 kcal mol-1) as well
as thermodynamically preferred, which is in agreement with experiment.  The energy
barrier is just in reach of the available inherent energy at room temperature97 which was
also confirmed by experiment.  The reaction was performed at room temperature and 3'-
acetyl PCU hydantoin was exclusively isolated.
In contrast to common hydantoins, PCU hydantoin is not protected at the stronger
nucleophilic N-1' nitrogen, but rather at the less sterically demanding, but much weaker
nucleophilic position (N-3').
It appears as if the cage systems lives up to it reputation: “Studies of such systems
provide an excellent test for existing chemical theory and thus perhaps furnish the best
opportunity for advancing the frontiers of our chemical knowledge.”110
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5. THE SYNTHESIS OF HYDANTOIN DERIVATIVES
5.1 Introduction
During the computational investigation (see Chapter 4), it was discovered that the
mono- and bis-Boc protected analogues of 5-methylhydantoin and 5,5-
dimethyhydantoin have not yet been reported before.107  The computational prediction
in Chapter 4 suggests that both the mono-Boc species should be protected at the N-1
nitrogen.  The purpose of this chapter is to discuss the uses of hydantoins and the
synthesis of the novel protected hydantoins in order to test the computational
predictions in Chapter 4.  A brief history of the pharmaceutical applications of
hydantoin derivatives is provided below.  Hydantoins were first applied as anti-epileptic






























One of the most commonly used anti-epileptic drugs is 5.5-diphenylhydantoin
(Phenyntoin, 83).  Other hydantoins such as 5-methyl-5-phenylhydantoin (mephynytoin,
84) and 3-ethyl-5-phenylhydantoin (85) had also been introduced for treatment of
epilepsy.111,112  Merrit et al were the first scientists to discover the anticonvulsant
activity of the phenyntoin in 1938.112,113  In 1945 about 700 substances were tested for
anticonvulsant activity.112  Most of the substances evaluated were hydantoins.  Some of
the characteristics for hydantoins to exhibit promising anticonvulsant activity are:112
• the hydantoin must have at least one phenyl group at carbon 5.
• substitution at the N-3' and N-1' positions with alkyl groups increase the
anticonvulsant activity.
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The first requirement is likely to be necessary for the transport of the drug across cell
membranes, especially to reach the CNS and the blood-brain barrier (BBB).  A benzene
substituent will improve the lypophilic character of the rather polar hydantoin, which is
a requirement for the transport of drugs across the cell membrane.  The chemical
structure of phenyntoin had been modified to extend the anticonvulsant activity.  3-
Hydroxyphenyntoin (86) did not show any positive activity.112  Substitution of the N-3'
hydrogen with an OH (86) group showed remarkable anticonvulsant activity.  Samour et
al114 evaluated the N-1' substituted derivatives (88) which showed low activity as

















In Chapter 2 it was demonstrated that the PCU Cage hydantoin (11) is selectively
acetylated at the N-3' position.  The lack of a phenyl substituent on the α-carbon is not
necessarily a major drawback as it was demonstrated in Chapter 1 that the PCU moiety
has shown excellent characteristics to deliver drugs to the CNS and to cross the BBB.6
The PCU hydantoin could therefore be studied for potential anti-epileptic activity as
substitution on N-3', which is required for increased anti-epileptic activity, can be
selectively performed.
5.2. Results and Discussion
The racemic hydantoins (72 and 73) were acetylated with t-Boc as in the case of












The novel mono-Boc protected 5-methylhydantoin (89) was synthesised using the






























































Scheme 18: Synthesis of mono- and bis-Boc protected-5-methylhydantoin
The product (89) was characterised with NMR, IR, MS and elemental analysis.  A
summary of the synthetic scheme is illustrated above (Scheme 18).  Previous work on
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the acetylation of 5-methylhydantoin with acetic anhydride indicated that the protection
occurs on the most nucleophilic N-1 nitrogen.79  When the acetylation was done with t-
Boc anhydride the NMR elucidation also indicated that the protection had occurred at
the N-1 position.  It was evident from the IR spectrum that the mono-Boc protection has
occurred due to the presence of three strong carbonyl group absorptions at 1800, 1736,
1720 cm-1.  Strong absorption band appears at 3288 cm-1 in the N-H stretching vibration
region.
The mass spectrum shows a molecular ion at m/z 215 [M+H]+ and it is the supportive of
























It was also evident from the 300 MHz 1H NMR data that mono-protection has occurred
due to the presence of the imide proton (H-3) at about 10 ppm20, and the absence of the
amide proton (H-1) at 6.40 ppm20 confirmed that the t-Boc group had attached to the
amide nitrogen (H-1).  The presence of a peak at 1.55 ppm is representative of three
methyl groups (H-8) and it integrates to nine protons.  The three hydrogens (H-10) of
the 5-methyl group were assigned to the doublets at 1.53 ppm.  This assignment was
further confirmed from a HETCOR spectrum of the sample which indicates a
correlation between H-10 at 1.53 ppm and C-10 at 16.81 ppm.  C-8 at 28.01 also shows
a HETCOR correlation with H-8 at 1.55 ppm.  H-9 which is attached to the hydantoin
ring and is assigned to the quartet (4.37-4.44 ppm); H-9 at 4.37-4.44 ppm shows a
HETCOR correlation with C-9 at 84.53 ppm.  Mono-protection was also confirmed by
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the presence of three carbonyl peaks in 13C NMR at 148.21, 151.56 and 171.66 ppm
respectively.  The peak at 171.66 ppm is associated with C-4 since it is positioned in an
electron deficient part of the molecule and it is therefore expected to be downfield.  C-5
is assigned to 148.22 ppm due the fact that C-5 is in the electron rich region and it is
therefore expected to be more upfield when compared to C-4 and C-2.  Using the same
analogy as above, C-2 was assigned to 151.56 ppm.
The novel bis-Boc protected hydantoin (91) was synthesised via the method of Kubik et
al38 which is a modification of the method of Hammer et al42  The method uses excess



































The product (91) was also characterised with NMR, IR and elemental analysis.  The
previous elucidation of mono-Boc protected hydantoin was useful for structural
elucidation of the bis-Boc protected derivative.  It was evident from the IR spectrum
that bis-Boc protection had occurred due to the presence of four strong carbonyl peaks
at 1778, 1724, 1736, 1826 cm-1 respectively.  It was also evident from the 1H NMR data
that bis-Boc protection occurred.  The two peaks at 1.53 and 1.55 ppm are typical for
the methyl protons of two tertiary butyl groups (H-8 and H-14) and each peak integrated
to nine protons.  Bis-Boc protection was also confirmed by the presence of four
carbonyl peaks in 13C NMR spectrum.  The mass spectrum shows a molecular ion at
m/z 314 [M+H]+ which is supportive of a molecular formula C14H22N2O6.  The same
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strategy as above was followed to elucidate the rest of the structure and the assignments






























































Scheme 19: Synthesis of mono- and bis-Boc protected-5.5-dimethylhydantoin
The novel mono-Boc protected 5.5-dimethylhydantoin (92) was synthesised using the
same method as described for the synthesis of 89.  It was evident from the IR spectrum
that the mono-Boc protection has occurred due to the presence of three strong carbonyl
peaks at 1729, 1767 and 1825 cm-1 respectively.  The strong peak at 3240 cm-1 is

























It was also evident from the 1H NMR data that mono-Boc protection has occurred due
to the absence of the amide proton (H-1) at about 6.4 ppm20, and the presence of the
imide proton (H-1) at 10 ppm20 confirmed that the t-Boc group was attached to the
amide nitrogen (N-1).  The peak at 1.55 ppm is characteristic of the three methyl groups
of a tertiary butyl group (H-8) and integrated to nine protons.  Mono-Boc protection was
further confirmed by the presence of three carbonyl peaks in the 13C NMR spectrum at
148.20, 151.92 and 172.51 ppm.  The previous 13C NMR elucidation of mono-Boc
protected 5-methylhydantoin was useful to assign C-5, C-2 and C-4 to 148.20, 151.92
and 172.51 ppm respectively.  The same strategy as before was followed to elucidate the
rest of the structure and the assignments are provided in the experimental section
(Chapter 6).
The novel bis-Boc protected 5.5-dimethyl hydantoin (94) was synthesised as described
for the synthesis of 91.  It was evident from the IR data that bis-Boc protection occurred
due to the presence of four strong carbonyl peaks at 1722, 1741, 1786, 1825 cm-1.  It
was also evident from the 1H NMR data that bis-Boc protection occurred.  The two
peaks at 1.553 and 1.551 ppm is characteristic of the methyl protons of two different
Boc groups and each signal integrated to nine protons.  The protection was confirmed







































The same strategy as before was followed to elucidate the rest of the structure and the
assignments are provided in the experimental section (Chapter 6).
5.3. Conclusion
Four novel compounds were synthesised (89, 91, 92, and 94).  The bis-Boc protected
hydantoins (91 and 94) may be used for an improved synthesis of alanine and amino-
isobutyric acid (AIB) respectively via base hydrolysis at room temperature.  The PCU
hydantoin (11) might be a valuable possibility as an antiepileptic drug as it is known6
that it enables entering the CNS and crossing the BBB.  It can also be conveniently
modified at N-3', a requirement for the synthesis of more active antiepileptic drug.  The
experimental results in this chapter verified the computational results in Chapter 4.  It
is clear that the computational model is applicable to correctly predict the regioselective
protection of hydantoins with anhydride.
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6. EXPERIMENTAL
Melting points were recorded using a Bombay 400 013 instrument from Shital
Scientific Industries.  All melting points are uncorrected.  Infrared spectra were obtained
using a Nicolet Impact 410 spectrometer.  The one-dimensional NMR spectra were
recorded on a Varian Gemini 300 MHz spectrometer, while the two-dimensional NMR
spectra were recorded on a Varian Unity Inova 400 MHz spectrometer.  The fast atom
bombardment (FAB) mass spectra were obtained from a Micromass VG70-70E mass
spectrometer, equipped with an In tech FAB gun.  The samples were bombarded with
xenon atoms (1 mA at 8 keV), with m-nitrobenzyl alcohol as the matrix.  Electron
impact (EI) mass spectra (70eV) were obtained from a Micromass Autospec-TOF mass
spectrometer.  Elemental analyses were obtained from a Leco CHNS 932 instrument.
HPLC analysis was performed using a Waters 600 solvent delivery system, equipped
with a Perkin Elmer series 700 autosampler, a Waters 996 photodiode array detector and
Millenium software.  A Nucleosil 100 C18 column (5 µm particle size, 250 mm x
4.6mm i.d.) was used.
6.1. Synthesis of 5,8-methano-4a,5,8,8a-tetrahydro-1,4-
naphthoquinone (14, adduct)115
p-Benzoquinone (200 g, 0.54 mol) was dissolved in dry toluene (4 l) and placed in an
ice/salt bath within a dark fume hood.  Cold, freshly cracked cyclopentadiene (132 ml,
1.96 mol) was added over two hours via a dropping funnel.  The slow addition and cool
temperatures allowed a successful Diels-Alder reaction, without dimerisation of the
cyclopentadiene or diaduct formation.  The reaction was left to return to room
temperature while stirring overnight.  The solution was evaporated in a dark fumehood
from a flat porcelain dish, yielding yellow crystals of the adduct.  The product of this
sample was recrystallized from petroleum ether (40-60°C) to yield 14 as yellow
crystals. (230g, 74% yield, m.p.77°C).  NMR and IR were identical to those of an
authentic sample.
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6.2. Synthesis of pentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-11-dione
(9)116
The adduct (200g, 1.15 mol, 14) was added to a volumetric flask (5.00 l) and dissolved
in 10 % (v/v) acetone in a hexane solution (5.00 l).  The volumetric flask was exposed
to direct sunlight until a colourless solution was obtained.  The photodimerization
normally takes three to five days in Durban.  The absence of the starting meterial was
confirmed with TLC (4% hexane/ethyl acetate).  The solvent was evaporated in vacuo
to give a white, microcrystalline solid of 9 (195g, 98%).  NMR and IR were identical to
those of an authentic sample.
6.3. Synthesis of pentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-11-dione-
mono-ethylene ketal (15)19
A mixture of the diketone 9 (183.00 g, 1.05 mol ), ethylene glycol (81.20 ml, 1.45 mol),
p-toluenesulfonic acid (6.11 g, 3.21x10-2 mol) and 4Å freshly regenerated molecular
sieves (2 g) in dry toluene (800 ml) was gently refluxed with stirring in a Dean and
Stark trap for four days.  The reaction mixture was left to cool and poured slowly into
ice-cold 10 % (v/v) aqueous sodium carbonate (1.00 l).  The aqueous mixture was
extracted with dichloromethane (3 x 500 ml).  The combined organic extracts were
dried over anhydrous sodium sulphate.  The mixture was filtered and the solvent
evaporated in vacuo.  The resulting brown residue was recrystallised from hexane to
give 15 as white crystals (170 g, 74 % ).  NMR and IR were identical to those of an
authentic sample.
6.4. Synthesis of 11-hydroxypentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-
one-eth-ylene ketal (16)30
The mono-ketal 15 (10.00 g, 4.59x10-2 mol) was dissolved in ethanol (100 ml) and
placed in an ice-bath to cool.  An ethanolic solution of sodium borohydride (3.50 g in 50
ml ethanol) was added, with stirring, over a 10 minute period.  The mixture was left to
stir for two hours in the ice-bath, and an additional two hours at room temperature.
Some sample (1 ml) was withdrawn to confirm complete reduction of the keto
functional group using IR spectroscopy.  The solvent of the reaction mixture was
removed in vacuo, and the residue extracted using dichloromethane (50 ml).  The
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solvent was removed in vacuo to leave 16 as a white solid (7.80 g, 78% yield, m.p. 250
°C).  NMR and IR were identical to those of an authentic sample.
6.5. Synthesis of 11-hydroxypentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-
one (17)19
The hydroxy-ketal (92.5g, 0.42 mol)was placed in an ice-bath to cool at which stage 10
% (v/v) hydrochloric acid (200 ml) was cautiously added.  This was left, with stirring, to
warm to room temperature for 18 hours.  The mixture was extracted with
dichloromethane (150 ml) and evaporated in vacuo to yield 17 (89.5 g, 96% yield, m.p.
255 °C).  NMR and IR were identical to those of an authentic sample.
6.6. Synthesis of endo-pentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-ol
(18)19,75
A mixture of the hydroxyketone 17 (13.00 g, 7.52x10-2 mol) and hydrazine hydrate
(23.10 ml, 0.74 mol) in diethylene glycol (200 ml) was refluxed, with stirring, at 120 °C
for two hours.  The mixture was allowed to cool to 80 °C at which stage excess KOH
(12.00 g, 0.21 mol) was added.  Excess hydrazine hydrate and water was distilled from
the mixture until the temperature reached 185 °C, thereafter, refluxed for a further three
hours at 185 °C.  The mixture was cooled, diluted with water (300 ml) and extracted
with dichloromethane (3x100 ml).  The combined organic phases were evaporated in
vacuo.  The yellow residue was steam distilled to yield the alcohol as a white solid with
a camphor-like odour (11.2 g, 56.3% yield, m.p. 231 °C).  NMR and IR were identical
to those of an authentic sample.
6.7. Synthesis of pentacyclo[5.4.0.02,6.03,10.05,9]undecanone (10)19
Chromium trioxide (14.00 g, 0.14 mol) was dissolved in deionised water (30 ml) and
added to acetic acid (320 ml).  The alcohol 18 (10.00 g, 0.0625 mol) was dissolved in
acetic acid (100 ml) and added drop-wise to the prepared mixture.  The reaction was
refluxed at 90 ºC overnight.  The successful oxidation (Jones oxidation) of the alcohol
was evident through reduction of Cr6+ (dark red) to Cr3+ (green).  The reaction mixture
was cooled, diluted with deionised water (1000 ml) and extracted with dichloromethane
(800 ml).  The organic extract was successively washed with water (2 x 500 ml), a
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saturated bicarbonate solution (2 x 500 ml) and water (500 ml).  The organic solution
was dried, using anhydrous sodium sulphate.  The mixture was filtered, and the solvent
removed in vacuo to yield pentacyclo[6.3.0.02,6.03,10.05,9]undecanone (7.5g, 76%, m.p.
195 °C).  NMR and IR were identical to those of an authentic sample.
6.8. Synthesis of PCU-hydantoin (11)19
A mixture of the monoketone 10 (1.00 g, 6.25x10-3 mol), NaCN (1.00 g, 2.04x10-2
mol), (NH4)2CO3 (2.00 g, 2.08x10-2 mol), ethanol (10 ml) and NH4OH (15 ml) were
sealed in a glass medium pressure vessel.  The reaction vessel was sealed in a metal
pressure vessel.  The reaction vessel was placed in an oil bath and heated at 60 ºC for
two hours, 100 ºC for two hours and 120 ºC overnight.  The cooled reaction was diluted
with deionised water (100 ml) and extracted with ethyl acetate (150 ml).  The solvent
was removed in vacuo to yield the crude hydantion.  The product was washed
successively with acetone and diethyl ether and thereafter, recrystallised from
tetrahydrofuran to yield pure hydantoin (11) as a white solid (1.4 g, 98% yield, m.p. 230
°C).  NMR and IR were identical to those of an authentic sample.
6.9 General Procedure for preparing mono-t-Boc-protected hydantoin
The method was adopted from the literature.42  A solution of hydantoin (11, 72 or 73)
(0.20 g, 2.17x10-3 mol), di-tert-butyl-dicarbonate (0.71 g, 3.26x10-3 mol), 4-dimethyl-
aminopyridine (DMAP) (3.00 mg, 2.17x10-5 mol) in dry THF (50 ml) was left to stir
under a nitrogen atmosphere for 24 hours.  The solution was concentrated in vacuo to
yield the crude product.
6.9.1. Synthesis of mono-t-Boc-protected PCU hydantoin (28)
Mono-t-Boc-protected PCU hydantoin (28) was prepared as described in the general
procedure (§6.9).  Purification was achieved through silica gel column chromatography
(dichloromethane) to yield the product (28) as a white powder.  (0.23 g, 74 %).  m.p.
206 °C.  IR (KBr) νmax 3305, 1803, 1765, 1718 cm-1.  1H NMR [CDCl3, 400 MHz]: δH
1.24-1.27 (1H, H4a, J 10.9 Hz), 1.63-1.66 (1H, H-4s, J 10.9 Hz), 1.39-1.43 (2H, H-11a,
H11s, J 12.5 Hz), 1.54 (9H, H-8'), 2.08 (H-5), 2.77 (H-1), 2.09 (H-3), 2.18 (H-1), 2.64
(H-2), 2.33 (H-9), 2.75 (H-6), 2.35 (H-10), 6.40 (H-1').  13C NMR [CDCl3, 100 MHz]:
δC 27.78 (C-8'), 41.49 (C-7), 28.04 (C-11), 43.18 (C-10), 41.44 (C-2), 49.03 (C-9),
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41.60 (C-6), 35.88 (C-1), 68.07 (C-8), 42.43 (C-5), 46.46 (C-3), 34.26 (C-4), 85.44 (C-
7'), 152.62 (C-2'), 146.28 (C-5'), 173.079 (C-4').  M.S. [M+H]+ 331 m/z.  Elemental
analysis.  Experimental: C, 65.54, H, 6.41, N 8.27 %.  Calculated: C, 65.45, H, 6.67, N,
8.48 %.
6.9.2. Synthesis of Mono-t-Boc-protected-5-methylhydantoin (89)
Mono-t-Boc-protected-5-methylhydantoin (89) was prepared as described in the general
procedure (§6.9).  Purification was achieved through silica gel column chromatography
(dichloromethane) to yield the product as a white powder (0.23 g, 74 %).  m.p. 121 °C.
IR (KBr) νmax 1826, 1778, 1736, 1724 cm-1.  1H NMR [CDCl3, 300 MHz]: δH 1.55 (9H,
H-8), 1.53 (9H, H-12), 4.37-4.44 (1H).  13C NMR [CDCl3, 75 MHz]: δC 27.97 (C-8),
55.30 (C-2), 16.96 (C-1), 86.71 (C-7), 148.26 (C-2), 147.34 (C-5), 168.01 (C-4), 84.92
(C-11), 142.26 (C-9).  M.S. [M+H]+ 314 m/z.  Elemental analysis.  Experimental: C,
50.07, H, 6.67, N 12.36 %.  Calculated: C, 50.70% H, 6.15% N, 13.14%
6.9.3. Synthesis of Mono-t-Boc-protected-5.5-dimethylhydantoin (92)
Mono-t-Boc-protected-5.5-dimethylhydantoin (92) was prepared as described in the
general procedure (§6.9).  The solution was concentrated in vacuo to yield the crude
product.  Purification was achieved through silica gel column chromatography
(dichloromethane) to yield the product as a white powder (0.23 g, 74 %).  m.p. 153 °C.
IR (KBr) νmax 3240, 1825, 1767, 1729 cm-1.  1H NMR [CDCl3, 300 MHz]: δH 1.55 (9H,
H-8'), 1.6 (6H), 11.29 (1H, H-3').  13C NMR [CDCl3, 75 MHz]: δC 28.01 (C-8), 84.53
(C-2), 16.81 (C-1), 57.16 (C-7'), 152.62 (C-2'), 148.22 (C-5'), 173.079 (C-4').  M.S.
[M+H]+ 227 m/z.  Elemental analysis.  Experimental: C, 53.47, H, 7.36, N 12.36 %.
Calculated: C, 52.86, H, 6.65, N, 12.33 %.
6.10. General Procedure for preparing Bis-t-Boc-protected hydantoin
The method was adobted from the literature.38  A solution of hydantoin (11, 72 and 73)
(0.20 g, 2.17x10-3 mol), di-tert-butyl-dicarbonate (1.19 g, 5.43x10-3 mol), 4-dimethyl-
aminopyridine (DMAP, 1.3 mg, 1.09x10-4 mol) and triethylamine (0.35 ml, 2.60x10-3
mol) in dry THF (50 ml) was left to stir under nitrogen gas for 24 hours.  The solution
was concentrated in vacuo to yield the crude product.  Purification was achieved
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through silica gel column chromatography (dichloromethane) to yield the product as a
white powder.
6.10.1. Synthesis of bis-t-Boc protected PCU hydantoin (30)
Bis-t-Boc-protected PCU hydantoin (30) was prepared as described in the general
procedure (§6.10) (0.57 g, 98 %).  m.p. 227 °C.  IR (KBr) νmax  1807, 1765, 1751, 1724
cm-1.  1H NMR [CDCl3, 400 MHz]: δH 1.64-1.67 (H-4s, J 10.4 Hz), 1.36-1.39 (H-11s, J
13.6 Hz), 1.23-1.24 (H-4a, J 10.4Hz), 1.25-1.26 (H-11a, J 4.03 Hz), 1.52 (9H, H-12'),
1.54 (9H, H-8'), 2.82 (H-1), 2.77 (H-6), 2.94 (H-5), 2.26 (H-9), 2.62 (H-2), 2.27 (H-3),
2.50 (H-10).  13C NMR [CDCl3, 100 MHz]: δC 27.73 (C-12'), 27.61 (C-8'), 29.15 (C-
11), 41.88 (C-7), 49.29 (C-9), 42.69 (C-10), 41.06 (C-6), 34.39 (C-1), 46.43 (C-8),
41.42 (C-2), 43.44 (C-3), 42.69 (C-5), 34.39 (C-4), 86.10 (C-11'), 84.90 (C-7'), 149.79
(C-2'), 149.71 (C-5'), 145.93 (C-9'), 171.65 (C-4').  M.S. [M+H]+ 431 m/z.  Elemental
analysis. Experimental: C, 63.91, H, 6.70, N, 6.39 %.  Calculated: C, 64.19, H, 6.98, N,
6.51 %.
6.10.2. Synthesis of bis-t-Boc-protected-5-methylhydantoin (91)
Bis-t-Boc-protected-5-methylhydantoin (91) was prepared as described in the general
procedure (§6.10) (0.43 g, 98 %).  m.p. 101 °C .  IR (KBr) νmax 1826, 1778, 1736, 1724
cm-1.  1H NMR [CDCl3, 300 MHz]: δH 1.55 (9H, H-8), 1.53 (9H, H-12), 4.37-4.44 (1H).
13C NMR [CDCl3, 75 MHz]: δC 27.97 (C-8), 55.30 (C-2), 16.96 (C-1), 86.71 (C-7),
148.26 (C-2), 147.34 (C-5), 168.01 (C-4), 84.92 (C-11), 142.26 (C-9).  M.S. [M+H]+
314 m/z.  Elemental analysis.  Experimental: C, 53.04, H, 7.43, N 8.94 %.  Calculated:
C, 53.49, H, 7.05, N, 8.91 %.
6.10.3. Synthesis of Bis-t-Boc-protected-5.5-dimethylhydantoin (94)
Bis-t-Boc-protected-5.5-dimethylhydantoin (94) was prepared as described in the
general procedure (§6.10).  (0.43 g, 98 %).  m.p. 115 °C.  IR (KBr) νmax 1825, 1786,
1741, 1722 cm-1.  1H NMR [CDCl3, 300 MHz]: δH 1.551 (9H, H-8), 1.553 (9H, H-12),
1.65 (6H).  13C NMR [CDCl3, 75 MHz]: δC 28.03 (C-8), 62.67 (C-2), 23.81 (C-1), 84.67
(C-7), 148.33 (C-2), 147.41 (C-5), 171.39 (C-4), 86.67 (C-11), 145.32 (C-9), 27.73 (C-
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12).  M.S. [M+H]+ 328 m/z.  Elemental analysis.  Experimental: C, 53.83, H, 7.25, N
8.81 %.  Calculated: C, 54.87, H, 7.37, N, 8.53 %.
6.11. Synthesis of Fmoc PCU amino acid (31)38
An aqueous solution of lithium hydroxide (8 mol equivalents) was added to a
suspension of 30 (0.2 g, 4.65X10-4 mol) and left to stir for 24 hours. The resulting light
yellow solution was extracted with Et2O (3 X 50mL) to remove Boc2NH.  The aqueous
layer containing the PCU amino acid was cooled in an ice bath and the pH of this
solution was adjusted to 6.5 with HCl.  This precooled solution was added dropwise to a
chilled mixture (ice bath) of 9-fluorenylmethyl chloroformate (0.15g, 5.8 X 10-4mol) in
dioxane.  A precipitate formed immediately, and the reaction mixture was allowed to
warm to room temperature, keeping the pH at 6-6.5 by addition of 10% LiOH.  The
reaction was left to stir overnight.  The dioxane was removed in vacuo and the resulting
aqueous layer was diluted with deionised water (50 ml) and extracted with diethyl ether
(100 ml) to remove unreacted Fmoc-Cl.  The aqueous layer was cooled to 10 °C in an
ice-bath and acidified to pH 2 with concentrated HCl.  The solution was subsequently
extracted with ethyl acetate (150 ml).  The organic solvent was evaporated in vacuo to
give the crude Fmoc PCU amino acid derivative which was recrystallised from
dichloromethane/hexane to yield white crystals 0.15g, 72%, m.p. 214 °C.  The NMR
and IR were identical to those of an authentic sample.
6.12. Synthesis of Fmoc PCU amino acid fluoride (32)43,49
Cyanuric fluoride (40.50 ul, 4.68x10-4 mol) was added to a suspension of Fmoc PCU
amino acid (0.20 g, 4.68x10-4 mol) and dry dichloromethane (50 ml).  Dry pyridine was
added (37.80 ul, 4.68x10-4 mol) and the resulting solution was left to stir under nitrogen
for 12 hours.  The mixture, which now contained a white suspension of water-soluble
cyanuric acid was extracted with ice water (40 ml).  The organic phase was dried over
MgSO4, filtered and removed in vacuo.  The resulting white solid was recrystallised
from dichloromethane/hexane to give the pure acid fluoride as a white solid (0.17 g, 87
%). The NMR and IR were identical to those of an authentic sample
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6.13. Coupling of linker to MBHA resin 40
The MBHA resin (0.50 g, 0.70 mmol NH2/g) was swelled by adding DMF to the 5ml
polypropylene syringe.  The FmocAM linker (0.47 g, 8.75x10-4 mol), DIPCDI (0.14 ml,
8.75x10-4 mol) and HOBt (0.12 g, 8.75x10-4 mol) were added at room temperature to
the resin in DMF.  This was left to stir for 24 hours.  Successful attachment was
confirmed by a negative Kaiser test.76  The Fmoc group was cleaved by the application
of a 20 % (v/v) piperidine in DMF solution for two hours.  Cleavage of the Fmoc group
was confirmed by a positive Kaiser test.  The Fmoc by-product was removed from the
solution by filtration, followed by washing the resin with isopropanol and DMF.
6.12. Washing procedure for solid phase peptide synthesis77
The resin was washed with DMF (3 x 10 ml), isopropanol (3 x 10 ml) and DMF (3 x 10
ml).
6.13. Coupling of Fmoc Alanine to the linker77
The Fmoc Alanine, DIPCDI (0.14 ml, 8.75x10-4 mol) and HOBt (0.12 g, 8.75x10-4 mol)
were added at room temperature to the resin in DMF.  This was left to stir for 24 hours.
Successful attachment was confirmed by a negative Kaiser test.  The Fmoc group was
cleaved by the application of a 20 % (v/v) piperidine in DMF solution for two hours.
Cleavage of the Fmoc group was confirmed by a positive Kaiser test.  The Fmoc group
was removed from the solution by filtration, followed by washing the resin with
isopropanol and DMF.
6.14. Coupling of Fmoc PCU amino acid fluoride to the tripeptide
bound resin 43
The PCU-amino acid fluoride (0.67 g, 1.56x10-3 mol) and dry pyridine (151.00 ul,
1.87x10-3 mol) was added to the resin in DMF and left to stir for 24 hours.  Successful
attachment was confirmed by a negative Kaiser test.  The Fmoc group was cleaved by
the application of a 20 % (v/v) piperidine in DMF solution for two hours.  The Fmoc
group was removed from the solution by filtration, followed by washing the resin with
isopropanol and DMF.
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6.15. Cleavage of the tetrapeptide from the resin and linker 77
The resin was separately washed with dichloromethane (3x10ml), methanol (3x10ml)
and diethyl ether (3x10ml) and dried overnight in a vacuum pump.  The dry resin was
placed in a flask containing the cleavage mixture of 95 % (v/v) TFA, 2.5 % (v/v) water
and 2.5 % (v/v) triisopropylsilane.  The mixture was left to stir for 12 hours.  The resin
was removed by filtration and washed several times with TFA.  The application of
nitrogen gas served to evaporate the TFA.  Diethyl ether was subsequently added to
precipitate the tetrapeptide as a white solid.  Decanting the diethyl ether served to
remove the linker from the peptide.
6.16. General procedure for HPLC analysis77
HPLC chromatographs of (46 and 47) are done from a solvent system which is made of
80 % (v/v) acetonitrile/20 % (v/v) water/0.1 % (v/v) trifluoroacetic acid (solution A)
and 100 % water (solution B) gradient system: 80 % solution A and 20 % solution B
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Chromatogram 35: HPLC chromatogram of penta-peptide (47) from an 80 % (v/v)
acetonitrile/20 % (v/v) water/0.1 % (
v/v) trifluoroacetic acid (solution A) and
100 % water (solution B) gradient system: 80 % solution A and 20 %
solution B was changed linearly to 40 % solution A and 60 % solution




























Chromatogram 36: HPLC chromatogram of tri-peptide from an 80 % (v/v)
acetonitrile/20 % (v/v) water/0.1 % (
v/v) trifluoroacetic acid (solution A) and
100 % water (solution B) gradient system: 80 % solution A and 20 %
solution B was changed linearly to 40 % solution A and 60 % solution
B at 1.00  ml min-1 over 50 minutes.
108

























































Chromatogram 39: HPLC chromatogram of tetra-peptide (46) from an 80 % (v/v)
acetonitrile/20 % (v/v) water/0.1 % (
v/v) trifluoroacetic acid (solution A) and
100 % water (solution B) gradient system: 80 % solution A and 20 %
solution B was changed linearly to 40 % solution A and 60 % solution










































































































































































































































































































































































































































































































































































































Transition state for 5-methylhydantoin (73) with acetic anhydride
 [(S,R)-TS-bot-N-3']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)






























Transition state for 5-methylhydantoin (73) with acetic anhydride
[(S,R)-TS-top-N-1']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)






























Transition state for 5-methylhydantoin (73) with acetic anhydride
 [(S,R)-TS-top-N-3']
#P B3LYP/6-31+G(D) OPT=( TS,NOEIGENTEST,GDIIS)






























Transition state for 5-methylhydantoin (73) with acetic anhydride
[(S,S)-TS-bot-N-3']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)






























Transition state for 5-methylhydantoin (73) with acetic anhydride
[(S,S)-TS-top-N-1']
#P B3LYP/6-31+G(D) OPT=(TS,NOEIGENTEST,GDIIS)





























Transition state for 5-methylhydantoin (73) with acetic anhydride
[(S,S)-TS-top-N-3']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)













































































Transition state for 5.5-dimethylhydantoin (73) with acetic anhydride [R-TS-N-1']
#P B3LYP/6-31+G(D) OPT=(TS,NOEIGENTEST,GDIIS)

































Transition state for 5.5-dimethylhydantoin (73) with acetic anhydride [R-TS-N-3']
#P B3LYP/6-31+G(D) OPT=(TS,NOEIGENTEST,GDIIS)

































Transition state for 5.5-dimethylhydantoin (73) with acetic anhydride [(S)-TS–N-1']
#P B3LYP/6-31+G(D) OPT=(TS,NOEIGENTEST,GDIIS)

































Transition state for 5.5-dimethylhydantoin (73) with acetic anhydride [(S)-TS-N-3']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)






















































































Transition state for PCU hydantoin (11) with acetic anhydride [(R,R)-TS-bot-N-1']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)















































Transition state for PCU hydantoin (11) with acetic anhydride [(R,R)-TS-bot-N-3']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)















































Transition state for PCU hydantoin (11) with acetic anhydride [(R,R)-TS-top-N-1']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)















































Transition state for PCU hydantoin (11) with acetic anhydride [(R,R)-TS-top-N-3']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)
















































Transition state for PCU hydantoin (11) with acetic anhydride [(R,S)-TS-bot-N-1']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)















































Transition state for PCU hydantoin (11) with acetic anhydride [(R,S)-TS-bot-N-3']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)















































Transition state for PCU hydantoin (11) with acetic anhydride [(R,S)-TS-top-N-1']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)















































Transition state for PCU hydantoin (11) with acetic anhydride [(R,S)-TS-top-N-3']
#P B3LYP/6-31+G(D) OPT=(CALCFC,TS,NOEIGENTEST)
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